The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition ... which is available in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

Humulin R is a short-acting insulin, while Humalog is a rapid-acting insulin ... Humulin R U-500 also comes in disposable, prefilled injection pens called KwikPens. Your doctor will show you ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

After all rebates and discounts are tallied, the typical patient today pays $5 per vial of Humalog, a popular insulin, and just $3.40 for its unbranded equivalent. Patients typically need about ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.